- Home
- LHSW vs ADAG Comparison
LHSW vs ADAG Comparison
Compare LHSW & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LHSW
- ADAG
- Stock Information
- Founded
- LHSW 2007
- ADAG 2011
- Country
- LHSW China
- ADAG China
- Employees
- LHSW N/A
- ADAG N/A
- Industry
- LHSW
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- LHSW
- ADAG Health Care
- Exchange
- LHSW NYSE
- ADAG Nasdaq
- Market Cap
- LHSW 81.6M
- ADAG 76.3M
- IPO Year
- LHSW 2025
- ADAG 2021
- Fundamental
- Price
- LHSW $2.31
- ADAG $2.09
- Analyst Decision
- LHSW
- ADAG Strong Buy
- Analyst Count
- LHSW 0
- ADAG 1
- Target Price
- LHSW N/A
- ADAG $8.00
- AVG Volume (30 Days)
- LHSW 883.8K
- ADAG 23.5K
- Earning Date
- LHSW 01-01-0001
- ADAG 07-24-2025
- Dividend Yield
- LHSW N/A
- ADAG N/A
- EPS Growth
- LHSW N/A
- ADAG N/A
- EPS
- LHSW 0.05
- ADAG N/A
- Revenue
- LHSW $36,718,017.00
- ADAG $103,204.00
- Revenue This Year
- LHSW N/A
- ADAG $6,488.89
- Revenue Next Year
- LHSW N/A
- ADAG $57.50
- P/E Ratio
- LHSW $48.49
- ADAG N/A
- Revenue Growth
- LHSW 24.85
- ADAG N/A
- 52 Week Low
- LHSW $0.99
- ADAG $1.33
- 52 Week High
- LHSW $8.18
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- LHSW N/A
- ADAG 69.13
- Support Level
- LHSW N/A
- ADAG $1.80
- Resistance Level
- LHSW N/A
- ADAG $1.84
- Average True Range (ATR)
- LHSW 0.00
- ADAG 0.14
- MACD
- LHSW 0.00
- ADAG 0.04
- Stochastic Oscillator
- LHSW 0.00
- ADAG 92.86
About LHSW LIANHE SOWELL INTERNATIONAL GROUP L
Lianhe Sowell International Group Ltd is a holding company and operates its business through its subsidiary. It is a provider of machine vision products and solutions in China that invent and integrate technologies and solutions that address some of the most critical manufacturing and distribution challenges, such as precision and accuracy required in manufacturing of electronic products. The company categorize machine vision products in four categories based on their application settings: Industrial Machine Vision, Artificial Intelligence (Face Recognition and AI Behavior Analysis), Intelligent Weak Current (Building Intelligence and Intelligent Transportation) and Electronic Customs Clearance.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.